Hledat
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Abstract
Microglia participates in the modulation of pain signaling. The activation of microglia is suggested to play an important role in affective disorders that are related to a dysfunction of the mesocorticolimbic system (MCLS) and are...
Implementace a strategie pracovních postupů pro integraci digitálních terapeutik pro poruchy spojené s užíváním alkoholu do primární péče: kvalitativní studie
Abstraktní
Pozadí
Poruchy spojené s užíváním alkoholu (AUD) jsou rozšířené a často se neléčí. Pacienti jsou běžně vyšetřováni na AUD v primární péči, ale stávající léčebné programy nedokážou uspokojit poptávku. Digitální terapie zahrnují...
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are common...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Seznam četby kokainu
Kokain je návyková stimulační droga, která pochází z listů rostliny koky, která pochází z Jižní Ameriky. Mezi účinky léku patří zvýšená bdělost, pozornost a energie, stejně jako pocity euforie a důvěry. Tyto účinky jsou však spojeny s...
Responding to stimulant use — developments in treatment
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year...
Exploring treatment barriers on the use of crystal methamphetamine among young people in Zimbabwe
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The study...
Trends in Overdose and Other Drug-Induced Deaths in Australia
This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
Adolescent Substance Use and Risk Behaviours in the Mediterranean Region
Preface
The Council of Europe is the continent’s leading human rights organisation. It comprises 46 member states, 27 of which are members of the European Union. All Council of Europe member states have signed up to the European Convention...
Report: Colloquium on “Responding to the nexus between adverse childhood experiences and drug use”
Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic
Abstract
Importance Information about the trend in illicit substance ingestions among young children during the pandemic is limited.
Objectives To assess immediate and sustained changes in overall illicit substance ingestion rates among...
PTACC Annual Deflection Summit Call for International Presenters
Proposals are now being accepted for the 2023 Police, Treatment, and Community Collaborative’s (PTACC) National Deflection and Pre-arrest Diversion Summit.
All submissions must be uploaded by May 5, 2023 at 2:00 EDT in order to be...
Parenting interventions in the context of prevention: New guidelines and a call for action
Časná expozice konopí a dlouhodobé následky v mozku
Colloquium on “Responding to the Nexus between Adverse Childhood Experiences and Drug Use”
ISSUP India conducted a one-day colloquium titled “Responding to the Nexus between Adverse Childhood Experiences and Drug Use” with the support of the Paul Hamlyn Foundation and National Drug Dependence Treatment Centre, AIIMS on 15th April...
Stigma, rodina a komunita
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member